Routine upstream versus selective downstream administration of glycoprotein IIb/IIIa inhibitors in patients with non-ST-elevation acute coronary syndromes: A meta-analysis of randomized trials

International Journal of Cardiology

Volumn 155, Issue 2, 2012, Pages 243-248

  Sciahbasi, Alessandro ^a   Biondi Zoccai, Giuseppe ^b   Romagnoli, Enrico ^a   Valgimigli, Marco ^c   Rasoul, Saman ^d   Van'T Hof, Arnoud ^d   Lioy, Ernesto ^a   Stone, Gregg W ^e  

^a ASL Roma B   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Cardiovascular Institute   (Italy)

^d ISALA HOSPITAL   (Netherlands)

^e Department of Medicine   (United States)

Author keywords

Acute coronary syndromes; Glycoprotein IIb IIIa inhibitors; Meta analysis; Upstream

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; TROPONIN;

ANGIOCARDIOGRAPHY; ARTERY CATHETERIZATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; DRUG EFFICACY; FOLLOW UP; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK ASSESSMENT; RISK REDUCTION;

ACUTE CORONARY SYNDROME; ELECTROCARDIOGRAPHY; HUMANS; PEPTIDES; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TYROSINE;

EID: 84857063385     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.10.010     Document Type: Article

References (25)

1. K.M. Anderson, R.M. Califf, and G.W. Stone Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention J Am Coll Cardiol 37 2001 2059 2065
2. E. Boersma, R.A. Harrington, and D.J. Moliterno Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomized clinical trials Lancet 359 2002 189 198
3. J.P. Bassand, C.W. Hamm, and D. Ardissino Guidelines for the diagnosis and treatment of non-ST-segment acute coronary syndromes Eur Heart J 28 2007 1598 1660
4. J.L. Anderson, C.D. Adams, and E.M. Antman ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 116 2007 803 877
5. G.W. Stone, M.E. Bertrand, and J.W. Moses Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes JAMA 297 2007 591 602
6. R.P. Giugliano, J.A. White, and C. Bode Early versus delayed provisional eptifibatide in acute coronary syndromes N Engl J Med 360 2009 2176 2190
7. J.P.T. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
8. A.W.J. van't Hof, S.T. De Vries, and J.H.E. Dambrink A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unstable Angina (ELISA) pilot study Eur Heart J 24 2003 1401 1405
9. M.T. Roe, R.H. Christenson, and E.M. Ohman A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes Am Heart J 146 2003 993 998
10. S. Rasoul, J.P. Ottervanger, and M.J. De Boer A comparison of dual vs triple antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndrome: results of the ELISA-2 trial Eur Heart J 27 2006 1401 1407
11. J.W. Eikelboom, S.R. Mehta, S.S. Anand, C. Xie, K.A.A. Fox, and S. Yusuf Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782
12. R. Meharan, S.J. Pocock, and G.W. Stone Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial Eur Heart J 30 2009 1457 1466
13. X.Q. Zhao, P. Theroux, S.M. Snapinn, and F.L. Sax Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction: angiographic results from the PRISM-PLUS trial Circulation 100 1999 1609 1615
14. M. van den Brand, G.J. Laarman, and P.G. Steg Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients: angiographic results from the CAPTURE trial Eur Heart J 20 1999 1572 1578
15. L. Bolognese, G. Falsini, and F. Liistro Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponine release in high-risk acute coronary syndromes treated with percutaneous coronary interventions J Am Coll Cardiol 47 2006 522 528
16. S.V. Rao, K. O'Grady, and K.S. Pieper Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Am J Cardiol 96 2005 1200 1206
17. S.V. Rao, J.A. Eikelboom, C.B. Granger, R.A. Harrington, R.M. Califf, and J.P. Bassand Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1193 1204
18. S.J. Pocock, R. Mehran, and T.C. Clayton Prognostic modelling of individual patient risk and mortality impact of ischemic and hemorrhagic complications Circulation 121 2010 43 51
19. C.B. Granger, R.J. Goldberg, and O. Dabbous Predictors of hospital mortality in the global registry of acute coronary events Arch Intern Med 163 2003 2345 2353
20. S. Subherwal, R.G. Bach, and A.Y. Chen Baseline risk of major bleeding in non-ST-segment elevation myocardial infarction Circulation 19 2009 1873 1882
21. S.S. Jolly, S. Amlani, M. Hamon, S. Yusuf, and S.R. Mehta Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials Am Heart J 157 2009 132 140
22. A. Sciahbasi, C. Pristipino, and G. Ambrosio Arterial access-site-related outcomes of patients undergoing invasive coronary procedures for acute coronary syndromes (from the comparison of early invasive and conservative treatment in patients with non-ST-elevation acute coronary syndromes [PRESTO-ACS] vascular substudy Am J Cardiol 103 2009 796 800
23. The OASIS Investigators Comparison of fondaparinux and enoxaparin in acute coronary syndromes N Engl J Med 354 2006 1464 1476
24. J.J. Ferguson, R.M. Califf, and E.M. Antman Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial JAMA 292 2004 45 54
25. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150